BlackRock Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $474K | Buy |
29,709
+1,523
| +5% | +$24.3K | ﹤0.01% | 2365 |
|
2016
Q3 | $470K | Buy |
28,186
+4,649
| +20% | +$77.5K | ﹤0.01% | 2318 |
|
2016
Q2 | $262K | Buy |
23,537
+8,938
| +61% | +$99.5K | ﹤0.01% | 2469 |
|
2016
Q1 | $123K | Buy |
14,599
+5,625
| +63% | +$47.4K | ﹤0.01% | 2680 |
|
2015
Q4 | $84K | Sell |
8,974
-292
| -3% | -$2.73K | ﹤0.01% | 2726 |
|
2015
Q3 | $105K | Buy |
9,266
+2,536
| +38% | +$28.7K | ﹤0.01% | 2683 |
|
2015
Q2 | $85K | Buy |
+6,730
| New | +$85K | ﹤0.01% | 2775 |
|
2014
Q3 | – | Sell |
-1,905
| Closed | -$31K | – | 2853 |
|
2014
Q2 | $31K | Buy |
+1,905
| New | +$31K | ﹤0.01% | 2718 |
|